Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors

Katherine E. McKenzie, Barbara A. Armstrong, Ying Chen, Mahalakshmi Nagarajan, C. Marcelo Aldaz, Saraswati Sukumar

Research output: Contribution to journalArticle

Abstract

Well-differentiated mammary carcinomas carrying mutated Ha-ras-1 oncogenes arise frequently in pubescent rats exposed to the direct-acting methylating agent N-methyl-N-nitrosourea (MNU). When these tumors are serially transplanted, they acquire more aggressive phenotypes. To determine the genetic alterations underlying local invasion, hormone independence, and metastasis, we studied alterations in the Ha-ras-1, p53, and mdm2 genes in successive generations of tumors passaged in intact or ovariectomized rats. Although previous studies have shown that selective amplification of the mutant Ha-ras-1 allele correlates strongly with the acquisition of hormone independence, we found that the acquisition of an invasive phenotype did not depend on mutational activation or amplification of Ha-ras-1. Mutations in the p53 gene were rare. Of a total of 120 primary, locally invasive, hormone- independent, and metastatic tumors tested for mutations in exons 4-9 of the p53 gene, only one mutation was detected in the later passages of an invasive tumor line. No gross gene alteration or amplification was seen in mdm2, a negative regulator of p53 transcription. Thus, the p53 gene is an infrequent mutational target, and amplification of the mdm2 gene does not appear to play a role in initiation or progression of rat mammary tumorigenesis.

Original languageEnglish (US)
Pages (from-to)194-203
Number of pages10
JournalMolecular Carcinogenesis
Volume20
Issue number2
DOIs
StatePublished - Oct 1997

Fingerprint

Methylnitrosourea
p53 Genes
Breast Neoplasms
Hormones
Mutation
Neoplasms
Phenotype
ras Genes
Gene Amplification
Exons
Carcinogenesis
Breast
Alleles
Neoplasm Metastasis
Genes

Keywords

  • Ha-ras-1
  • mdm2
  • N-methyl-N-nitrosourea
  • p53
  • Rat mammary carcinoma

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors. / McKenzie, Katherine E.; Armstrong, Barbara A.; Chen, Ying; Nagarajan, Mahalakshmi; Aldaz, C. Marcelo; Sukumar, Saraswati.

In: Molecular Carcinogenesis, Vol. 20, No. 2, 10.1997, p. 194-203.

Research output: Contribution to journalArticle

McKenzie, Katherine E. ; Armstrong, Barbara A. ; Chen, Ying ; Nagarajan, Mahalakshmi ; Aldaz, C. Marcelo ; Sukumar, Saraswati. / Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors. In: Molecular Carcinogenesis. 1997 ; Vol. 20, No. 2. pp. 194-203.
@article{beb796b5f8e643428e57f33a80205e74,
title = "Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors",
abstract = "Well-differentiated mammary carcinomas carrying mutated Ha-ras-1 oncogenes arise frequently in pubescent rats exposed to the direct-acting methylating agent N-methyl-N-nitrosourea (MNU). When these tumors are serially transplanted, they acquire more aggressive phenotypes. To determine the genetic alterations underlying local invasion, hormone independence, and metastasis, we studied alterations in the Ha-ras-1, p53, and mdm2 genes in successive generations of tumors passaged in intact or ovariectomized rats. Although previous studies have shown that selective amplification of the mutant Ha-ras-1 allele correlates strongly with the acquisition of hormone independence, we found that the acquisition of an invasive phenotype did not depend on mutational activation or amplification of Ha-ras-1. Mutations in the p53 gene were rare. Of a total of 120 primary, locally invasive, hormone- independent, and metastatic tumors tested for mutations in exons 4-9 of the p53 gene, only one mutation was detected in the later passages of an invasive tumor line. No gross gene alteration or amplification was seen in mdm2, a negative regulator of p53 transcription. Thus, the p53 gene is an infrequent mutational target, and amplification of the mdm2 gene does not appear to play a role in initiation or progression of rat mammary tumorigenesis.",
keywords = "Ha-ras-1, mdm2, N-methyl-N-nitrosourea, p53, Rat mammary carcinoma",
author = "McKenzie, {Katherine E.} and Armstrong, {Barbara A.} and Ying Chen and Mahalakshmi Nagarajan and Aldaz, {C. Marcelo} and Saraswati Sukumar",
year = "1997",
month = "10",
doi = "10.1002/(SICI)1098-2744(199710)20:2<194::AID-MC6>3.0.CO;2-N",
language = "English (US)",
volume = "20",
pages = "194--203",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Alterations in the Ha-ras-1 and the p53 pathway genes in the progression of N-methyl-N-nitrosourea-induced rat mammary tumors

AU - McKenzie, Katherine E.

AU - Armstrong, Barbara A.

AU - Chen, Ying

AU - Nagarajan, Mahalakshmi

AU - Aldaz, C. Marcelo

AU - Sukumar, Saraswati

PY - 1997/10

Y1 - 1997/10

N2 - Well-differentiated mammary carcinomas carrying mutated Ha-ras-1 oncogenes arise frequently in pubescent rats exposed to the direct-acting methylating agent N-methyl-N-nitrosourea (MNU). When these tumors are serially transplanted, they acquire more aggressive phenotypes. To determine the genetic alterations underlying local invasion, hormone independence, and metastasis, we studied alterations in the Ha-ras-1, p53, and mdm2 genes in successive generations of tumors passaged in intact or ovariectomized rats. Although previous studies have shown that selective amplification of the mutant Ha-ras-1 allele correlates strongly with the acquisition of hormone independence, we found that the acquisition of an invasive phenotype did not depend on mutational activation or amplification of Ha-ras-1. Mutations in the p53 gene were rare. Of a total of 120 primary, locally invasive, hormone- independent, and metastatic tumors tested for mutations in exons 4-9 of the p53 gene, only one mutation was detected in the later passages of an invasive tumor line. No gross gene alteration or amplification was seen in mdm2, a negative regulator of p53 transcription. Thus, the p53 gene is an infrequent mutational target, and amplification of the mdm2 gene does not appear to play a role in initiation or progression of rat mammary tumorigenesis.

AB - Well-differentiated mammary carcinomas carrying mutated Ha-ras-1 oncogenes arise frequently in pubescent rats exposed to the direct-acting methylating agent N-methyl-N-nitrosourea (MNU). When these tumors are serially transplanted, they acquire more aggressive phenotypes. To determine the genetic alterations underlying local invasion, hormone independence, and metastasis, we studied alterations in the Ha-ras-1, p53, and mdm2 genes in successive generations of tumors passaged in intact or ovariectomized rats. Although previous studies have shown that selective amplification of the mutant Ha-ras-1 allele correlates strongly with the acquisition of hormone independence, we found that the acquisition of an invasive phenotype did not depend on mutational activation or amplification of Ha-ras-1. Mutations in the p53 gene were rare. Of a total of 120 primary, locally invasive, hormone- independent, and metastatic tumors tested for mutations in exons 4-9 of the p53 gene, only one mutation was detected in the later passages of an invasive tumor line. No gross gene alteration or amplification was seen in mdm2, a negative regulator of p53 transcription. Thus, the p53 gene is an infrequent mutational target, and amplification of the mdm2 gene does not appear to play a role in initiation or progression of rat mammary tumorigenesis.

KW - Ha-ras-1

KW - mdm2

KW - N-methyl-N-nitrosourea

KW - p53

KW - Rat mammary carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030715568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030715568&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2744(199710)20:2<194::AID-MC6>3.0.CO;2-N

DO - 10.1002/(SICI)1098-2744(199710)20:2<194::AID-MC6>3.0.CO;2-N

M3 - Article

VL - 20

SP - 194

EP - 203

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 2

ER -